反应详情

A solution of (S)-methyl 2-tert-butoxy-2-(7-(4-chlorophenyl)-2-(1,3-dimethyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-5-methylbenzo[d]thiazol-6-yl)acetate (38 mg, 0.07 mmol) and 5M sodium hydroxide (0.28 mL, 1.4 mmol) in THF (2 mL) and MeOH (0.5 mL) was stirred at 50° C. for 2 h. Reaction mixture was cooled to rt, acetic acid (88 μL) and DMF (0.3 mL) were added and reaction mixture was concentrated to ˜0.3 mL, filtered, purified by Gilson HPLC (Gemini, 5 to 100% ACN/H2O+0.1% TFA) and lyophilized to give desired product. LCMS-ESI+: calc'd for C27H27ClN5O3S: 536.1 (M+H+); Found: 536.2 (M+H+); 1H NMR (400 MHz, CD3OD) δ 9.29 (s, 1H), 7.92 (s, 1H), 7.71 (d, J=8.0 Hz, 1H), 7.62 (br s, 3H), 5.28 (s, 1H), 4.13 (s, 3H), 2.63 (s, 6H), 0.98 (s, 9H).

1. customReaction mixture
2. customreaction mixture
3. concentrationwas concentrated to ˜0.3 mL
4. filtrationfiltered
5. custompurified by Gilson HPLC (Gemini, 5 to 100% ACN/H2O+0.1% TFA)